$VIVS 4 SEC Filings

Filed On	Filing
01 Sep 2026	Form 4: Lialin Tony Serge, Chief Commercial Officer Bought 10,000 shares ($2.8K)
29 Jan 2026	Form 4: Cohen Douglas Jay, Director Received 15,000 shares as a grant or award
29 Jan 2026	Form 4: Murphy Keith, Director Received 15,000 shares as a grant or award
29 Jan 2026	Form 4: Milhous Alison Tjosvold, Director Received 15,000 shares as a grant or award
29 Jan 2026	Form 4: Gobel David, Director Received 15,000 shares as a grant or award
29 Jan 2026	Form 4: Stern Adam K, Director Received 15,000 shares as a grant or award
26 Nov 2025	Form 4: Sethi Amar Akhtar, Chief Scientific Officer Granted 53,500 Options (right to buy)
19 Nov 2025	Form 4: Gobel David, Director Acquired 3,266 shares (Open Market Sale) ($7.3K)
21 Aug 2025	Form 4: Lialin Tony Serge, Chief Commercial Officer Granted 40,000 Options (right to buy)
09 Aug 2024	Form 4: Gobel David, Director Received 19,607 shares as a grant or award
09 Aug 2024	Form 4: Cohen Douglas Jay, Director Received 19,607 shares as a grant or award
09 Aug 2024	Form 4: Milhous Alison Tjosvold, Director Received 19,607 shares as a grant or award
09 Aug 2024	Form 4: Stern Adam K, Director Received 19,607 shares as a grant or award
09 Aug 2024	Form 4: Joshi Vaidehi, Director Received 19,607 shares as a grant or award
07 Aug 2024	Form 4: Murphy Keith, Director Granted 718,654 Options (right to buy) · Received 19,607 shares as a grant or award
17 Nov 2023	Form 4: Stern Adam K, Director Received 19,607 shares as a grant or award
17 Nov 2023	Form 4: Milhous Alison Tjosvold, Director Received 19,607 shares as a grant or award
17 Nov 2023	Form 4: Cohen Douglas Jay, Director Received 19,607 shares as a grant or award
17 Nov 2023	Form 4: Murphy Keith, Director Received 19,607 shares as a grant or award
17 Nov 2023	Form 4: Gobel David, Director Sold 19,607 shares ($31.7K) · Received 19,607 shares as a grant or award

Comments